PreFIT addresses the need for better
“diagnostic tools for tuberculosis”
The situation
In Africa in 2022, TB was responsible for 2.48 million cases of disease (461,000 of whom co-infected with HIV) and 424,000 deaths.
0
lives saved since 2000 by global efforts to end TB
0
people fell ill with TB in 2022
0
people died of TB in 2022
Whom
PreFIT partnership covers all aspects of the task at hand.
Partnership is uniquely fit-for-purpose
METHODOLOGY
Excellent track of working together in research and capacity-building consortia
CAPACITY
For large-scale case-contact follow-up studies
RESEARCH
Leading expertise in TB diagnostic studies, capacity for large-scale case-contact follow-up studies
NETWORK
Unique network and knowledge regarding diagnostic development and market introduction
Consortium
The PreFIT consortium, led by the Amsterdam Institute for Global Health and Development
Its ultimate goal is to help close the gaps in health disparities between and within different regions of the world.
Our vision
Is to validate assays for improved prediction of progression from latent tuberculosis infection (LTBI) to active tuberculosis (TB) disease
News
Information about Tuberculosis
Patience and empathy to predict Tuberculosis in Mozambique
Patience and empathy to predict Tuberculosis in Mozambique* *The article was originally published in Planeta Futuro, El Pais. ...
Partners Met For The Third Annual Consortium Meeting In Maputo
Partners Met For The Third Annual Consortium Meeting In Maputo The third Annual Consortium Meeting of PreFIT was ...
PreFIT finished its recruitment process in Mozambique, Uganda and South Africa
On January 31st, 2024, the recruitment process for the PreFIT project officially came to an end. The three study ...
Partners
Information about Consortium
